2023 Q3 Form 10-Q Financial Statement

#000162828023026380 Filed on August 01, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $5.928B $6.075B
YoY Change 11.58% 13.81%
Cost Of Revenue $4.531B $4.653B
YoY Change 10.86% 13.27%
Gross Profit $1.397B $1.422B
YoY Change 13.95% 15.61%
Gross Profit Margin 23.57% 23.41%
Selling, General & Admin $239.0M $240.0M
YoY Change 10.65% 3.9%
% of Gross Profit 17.11% 16.88%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $69.00M $70.00M
YoY Change -4.17% 2.94%
% of Gross Profit 4.94% 4.92%
Operating Expenses $285.0M $288.0M
YoY Change 7.14% 2.86%
Operating Profit $1.099B $1.134B
YoY Change 14.72% 19.37%
Interest Expense $146.0M -$132.0M
YoY Change 46.0% -238.95%
% of Operating Profit 13.28% -11.64%
Other Income/Expense, Net $28.00M $2.000M
YoY Change 833.33% 0.0%
Pretax Income $989.0M $964.0M
YoY Change 13.81% 9.79%
Income Tax $237.0M $238.0M
% Of Pretax Income 23.96% 24.69%
Net Earnings $752.0M $726.0M
YoY Change 19.37% 7.08%
Net Earnings / Revenue 12.69% 11.95%
Basic Earnings Per Share $2.52 $2.39
Diluted Earnings Per Share $2.51 $2.38
COMMON SHARES
Basic Shares Outstanding 298.2M shares 303.4M shares
Diluted Shares Outstanding 300.1M shares 305.0M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $717.0M $563.0M
YoY Change -31.39% 3.11%
Cash & Equivalents $717.0M $563.0M
Short-Term Investments
Other Short-Term Assets $262.0M $316.0M
YoY Change 0.38% 13.67%
Inventory
Prepaid Expenses
Receivables $2.703B $2.565B
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.682B $3.444B
YoY Change -0.05% 10.88%
LONG-TERM ASSETS
Property, Plant & Equipment $1.572B $2.525B
YoY Change 4.17% 64.82%
Goodwill $8.795B $8.850B
YoY Change 0.34% -0.78%
Intangibles
YoY Change
Long-Term Investments $311.0M $311.0M
YoY Change -6.33% -14.33%
Other Assets $578.0M $822.0M
YoY Change 3.4% 43.71%
Total Long-Term Assets $21.59B $21.64B
YoY Change 2.4% 0.62%
TOTAL ASSETS
Total Short-Term Assets $3.682B $3.444B
Total Long-Term Assets $21.59B $21.64B
Total Assets $25.27B $25.09B
YoY Change 2.04% 1.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $696.0M $670.0M
YoY Change -6.7% -13.32%
Accrued Expenses $2.716B $2.584B
YoY Change 0.07% 7.35%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $898.0M $894.0M
YoY Change 60.93% 60.22%
Total Short-Term Liabilities $7.677B $7.520B
YoY Change 7.94% 9.73%
LONG-TERM LIABILITIES
Long-Term Debt $10.87B $10.40B
YoY Change 22.69% 26.4%
Other Long-Term Liabilities $1.622B $7.103B
YoY Change -10.44% 278.83%
Total Long-Term Liabilities $1.622B $17.51B
YoY Change -10.44% 833.65%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.677B $7.520B
Total Long-Term Liabilities $1.622B $17.51B
Total Liabilities $9.299B $25.31B
YoY Change 4.21% 190.0%
SHAREHOLDERS EQUITY
Retained Earnings $14.14B $13.54B
YoY Change 19.9% 20.26%
Common Stock $6.001B $5.957B
YoY Change 1.3% 1.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$661.0M -$224.0M
YoY Change
Total Liabilities & Shareholders Equity $25.27B $25.09B
YoY Change 2.04% 1.92%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $752.0M $726.0M
YoY Change 19.37% 7.08%
Depreciation, Depletion And Amortization $69.00M $70.00M
YoY Change -4.17% 2.94%
Cash From Operating Activities $881.0M $651.0M
YoY Change 0.8% 0.15%
INVESTING ACTIVITIES
Capital Expenditures $124.0M $99.00M
YoY Change -269.86% -241.43%
Acquisitions
YoY Change
Other Investing Activities $4.000M -$85.00M
YoY Change -85.19% -4350.0%
Cash From Investing Activities -$120.0M -$184.0M
YoY Change 160.87% 170.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -597.0M -459.0M
YoY Change 82.57% -57.58%
NET CHANGE
Cash From Operating Activities 881.0M 651.0M
Cash From Investing Activities -120.0M -184.0M
Cash From Financing Activities -597.0M -459.0M
Net Change In Cash 164.0M 8.000M
YoY Change -67.27% -101.6%
FREE CASH FLOW
Cash From Operating Activities $881.0M $651.0M
Capital Expenditures $124.0M $99.00M
Free Cash Flow $757.0M $552.0M
YoY Change -20.06% -23.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
mar Payments For Loan Advances
PaymentsForLoanAdvances
17000000 usd
us-gaap Proceeds From Sale And Collection Of Notes Receivable
ProceedsFromSaleAndCollectionOfNotesReceivable
33000000 usd
us-gaap Proceeds From Sale And Collection Of Notes Receivable
ProceedsFromSaleAndCollectionOfNotesReceivable
9000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-37000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-22000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-243000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-91000000 usd
mar Proceeds From Repayments Of Commercial Paper And Long Term Lines Of Credit
ProceedsFromRepaymentsOfCommercialPaperAndLongTermLinesOfCredit
736000000 usd
mar Proceeds From Repayments Of Commercial Paper And Long Term Lines Of Credit
ProceedsFromRepaymentsOfCommercialPaperAndLongTermLinesOfCredit
-750000000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
783000000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
330000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
576000000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
281000000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
98000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2046000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
300000000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
79000000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
87000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-24000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1241000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1811000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
54000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-854000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
525000000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1421000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
579000000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
567000000 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
18000000 usd
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
16000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
726000000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
678000000 usd
us-gaap Net Income Loss
NetIncomeLoss
1483000000 usd
us-gaap Net Income Loss
NetIncomeLoss
1055000000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
303600000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
328200000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
306600000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
328300000 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.39
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.84
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.21
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
726000000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
678000000 usd
us-gaap Net Income Loss
NetIncomeLoss
1483000000 usd
us-gaap Net Income Loss
NetIncomeLoss
1055000000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
303600000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
328200000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
306600000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
328300000 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1400000 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1300000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1400000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1500000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
305000000.0 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
329500000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
308000000.0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
329800000 shares
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.38
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.81
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.20
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
166
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
49000000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
49000000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
82000000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
91000000 usd
CY2023Q2 mar Share Based Compensation Nonvested Awards Compensation Cost Not Yet Recognized
ShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognized
267000000 usd
CY2022Q4 mar Share Based Compensation Nonvested Awards Compensation Cost Not Yet Recognized
ShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognized
179000000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.247
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.228
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.18
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.221
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
-98000000 usd
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
157000000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
255000000 usd
CY2023Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
146000000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
241000000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
125000000 usd
CY2023Q2 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
249000000 usd
CY2023Q2 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
101000000 usd
CY2023Q2 us-gaap Commercial Paper Noncurrent
CommercialPaperNoncurrent
1641000000 usd
CY2022Q4 us-gaap Commercial Paper Noncurrent
CommercialPaperNoncurrent
871000000 usd
CY2023Q2 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2023Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
135000000 usd
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
139000000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
56000000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
92000000 usd
CY2023Q2 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
11297000000 usd
CY2022Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
10064000000 usd
CY2023Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
894000000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
684000000 usd
CY2023Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
10403000000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
9380000000 usd
us-gaap Interest Paid Net
InterestPaidNet
196000000 usd
us-gaap Interest Paid Net
InterestPaidNet
179000000 usd
CY2023Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
4500000000 usd
us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
11000000 usd
us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
-2000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
13000000 usd
us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-308000000 usd
us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
1000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-309000000 usd
mar Other Comprehensive Income Loss Foreign Currency Translation And Translation Gain Loss Before Reclassification And Tax Intra Entity Foreign Currency Transactions Long Term Investment Nature
OtherComprehensiveIncomeLossForeignCurrencyTranslationAndTranslationGainLossBeforeReclassificationAndTaxIntraEntityForeignCurrencyTransactionsLongTermInvestmentNature
-14000000 usd
mar Other Comprehensive Income Loss Foreign Currency Translation And Translation Gain Loss Before Reclassification And Tax Intra Entity Foreign Currency Transactions Long Term Investment Nature
OtherComprehensiveIncomeLossForeignCurrencyTranslationAndTranslationGainLossBeforeReclassificationAndTaxIntraEntityForeignCurrencyTransactionsLongTermInvestmentNature
44000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
568000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
757000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
82000000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.40
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
124000000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-34000000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1109000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
140000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
726000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-69000000 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.52
CY2023Q2 us-gaap Dividends Common Stock
DividendsCommonStock
157000000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
48000000 usd
CY2023Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
912000000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-224000000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1414000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
377000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
14000000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1772000000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
678000000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-323000000 usd
CY2022Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.30
CY2022Q2 us-gaap Dividends Common Stock
DividendsCommonStock
98000000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
43000000 usd
CY2022Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
300000000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1772000000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
191000000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2023Q2 us-gaap Revenues
Revenues
6075000000 usd
CY2022Q2 us-gaap Revenues
Revenues
5338000000 usd
us-gaap Revenues
Revenues
11690000000 usd
us-gaap Revenues
Revenues
9537000000 usd
CY2023Q2 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-141000000 usd
CY2022Q2 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-89000000 usd
us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-252000000 usd
us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-177000000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
238000000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
325000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
299000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
726000000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
678000000 usd
us-gaap Net Income Loss
NetIncomeLoss
1483000000 usd
us-gaap Net Income Loss
NetIncomeLoss
1055000000 usd
CY2023Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001628280-23-026380-index-headers.html Edgar Link pending
0001628280-23-026380-index.html Edgar Link pending
0001628280-23-026380.txt Edgar Link pending
0001628280-23-026380-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
image_0.jpg Edgar Link pending
image_0a.jpg Edgar Link pending
image_0b.jpg Edgar Link pending
mar-20230630.htm Edgar Link pending
mar-20230630.xsd Edgar Link pending
mar-20230630_g1.jpg Edgar Link pending
mar-q22023xexx102.htm Edgar Link pending
mar-q22023xexx103.htm Edgar Link pending
mar-q22023xexx104.htm Edgar Link pending
mar-q22023xexx311.htm Edgar Link pending
mar-q22023xexx312.htm Edgar Link pending
mar-q22023xexx32.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
mar-20230630_lab.xml Edgar Link unprocessable
mar-20230630_pre.xml Edgar Link unprocessable
mar-20230630_htm.xml Edgar Link completed
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
mar-20230630_def.xml Edgar Link unprocessable
mar-20230630_cal.xml Edgar Link unprocessable